FK506MR + Prograf + Mycophenolate Mofetil + Methylprednisolone + Prednisolone

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Kidney Transplantation

Conditions

Kidney Transplantation

Trial Timeline

Jul 1, 2007 โ†’ Mar 1, 2009

About FK506MR + Prograf + Mycophenolate Mofetil + Methylprednisolone + Prednisolone

FK506MR + Prograf + Mycophenolate Mofetil + Methylprednisolone + Prednisolone is a phase 3 stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00481819. Target conditions include Kidney Transplantation.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00481819Phase 3Completed

Competing Products

20 competing products in Kidney Transplantation

See all competitors
ProductCompanyStageHype Score
Empagliflozin + Matching placeboEli LillyPhase 3
77
Baricitinib + PlaceboEli LillyPhase 2
52
SGLT2 inhibitorEli LillyPre-clinical
23
LY2623091 + EplerenoneEli LillyPhase 2
52
Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
85
TacrolimusAstellas PharmaApproved
85
RituximabAstellas PharmaPhase 2
52
Prograf + MR4Astellas PharmaPhase 3
77
basiliximab + rabbit anti-thymocyte globulin + tacrolimus + alemtuzumab + mycophenolate mofetil + steroidsAstellas PharmaApproved
85
Tacrolimus, modified releaseAstellas PharmaPhase 3
77
Tacrolimus granulesAstellas PharmaApproved
85
roxadustatAstellas PharmaPhase 3
77
Tacrolimus immediate-release formulation + Tacrolimus prolonged-release formulation + Induction therapy + Mycophenolic acid drugs + CorticosteroidsAstellas PharmaApproved
85
ASP1128 + PlaceboAstellas PharmaPhase 2
52
MMF (Cellcept) and Steroids + Tacrolimus (Prograf)Astellas PharmaApproved
85
ASP1585Astellas PharmaPhase 3
77
Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + CorticosteroidsAstellas PharmaPhase 2
52
Advagraf + Mycophenolate Mofetil + Simulect + CorticosteroidsAstellas PharmaApproved
85
tacrolimusAstellas PharmaApproved
85
roxadustatAstellas PharmaPhase 3
77